Changing utilization of pro re nata ('as needed') sedation in a child and adolescent psychiatric inpatient unit

Angela J Dean1, James Scott, Brett M McDermott

  • 1Kids in Mind Research, Mater Child and Youth Mental Health Service, Qld, Australia. angela.dean@mater.org.au

Insights

Utilization of as-needed (PRN) sedation in child and adolescent psychiatric units significantly decreased over time. This reduction in PRN sedation occurred independently of changes in patient characteristics, suggesting potential for optimization.

Area of Science:

  • Child and Adolescent Psychiatry
  • Psychopharmacology
  • Healthcare Quality Improvement

Background:

  • Pro re nata (PRN; as-needed) sedation is frequently used in child and adolescent psychiatric inpatient settings.
  • Understanding trends and influencing factors in PRN sedation use is crucial for optimizing patient care.

Purpose of the Study:

  • To investigate changes in the utilization of PRN sedation over time in a child and adolescent psychiatric inpatient unit.
  • To determine if observed changes in PRN sedation use correlate with shifts in patient demographics or clinical characteristics.

Main Methods:

  • A retrospective chart review of 257 patient records from a child and youth mental health inpatient service across two distinct time periods (Wave I and Wave II).
  • Data collection included PRN sedation prescriptions and administration, patient characteristics, and concurrent routine medication use.

Main Results:

  • A significant decrease in the proportion of patients prescribed PRN sedation (70% to 54%) and administered PRN sedation (46% to 26%) was observed over time (p < 0.01).
  • Chlorpromazine was the most common PRN drug in Wave I, while diazepam was most common in Wave II.
  • Multivariate analysis confirmed that the reduction in PRN sedation was independent of changes in patient characteristics.

Conclusions:

  • High rates of PRN sedation are not an immutable feature of child and adolescent psychiatric inpatient care and can be effectively reduced.
  • The observed decrease in PRN sedation utilization was not linked to changes in the patient population.
  • Further research into treatment outcomes is necessary to refine and optimize the use of PRN sedation in pediatric mental health settings.
Abstract

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Stages of General Anesthesia01:22

Stages of General Anesthesia

Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...